Article Details

Analyst Stock Recommendations For ImmunoCellular Therapeutics, Ltd. (IMUC), Nxt-ID, Inc. (NXTD)

Retrieved on: 2018-06-26 00:40:35

Tags for this article:

Click the tags to see associated articles and topics

Analyst Stock Recommendations For ImmunoCellular Therapeutics, Ltd. (IMUC), Nxt-ID, Inc. (NXTD). View article details on hiswai:

Excerpt

<div>ImmunoCellular Therapeutics, Ltd. (NYSE:IMUC) tinted loss of -4.31% (-0.01 points) to US$0.25. The volume of 0.29 Million shares climbed down over ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up